Your search for "financial results" return 19 results.
Research & Development >
With innovation being one of our corporate values, we place great emphasis on the need to continually shift scientific boundaries. Our research teams are located around the world, as the need to find...
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
USA: Ceva acquires Summit VetPharm, LLC - 26th August 2010 >
LENEXA, Kan.— Ceva, a global veterinary pharmaceutical group, is pleased to announce the company has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquir...
Nomination : Corporate Marketing Directors - 13th July 2010 >
Ceva reinforces the management of its marketing organisation with the recruitment of two key executives
Legal notice >
By accessing the Site, the internet user agrees to comply with and respect the terms of use defined below
Who are we? >
CEVA Animal Health is part of a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for livestock, poultry and pets....